Page 51 - Read Online
P. 51

Page 16 of 20                                                Singh et al. Cancer Drug Resist. 2025;8:56





               29.  Hussen BM, Abdullah SR, Jaafar RM, et al. Circular RNAs as key regulators in cancer hallmarks: new progress and therapeutic
                  opportunities. Crit Rev Oncol Hematol. 2025;207:104612. DOI PubMed
               30.  Yang Q, Li F, He AT, Yang BB. Circular RNAs: expression, localization, and therapeutic potentials. Mol Ther. 2021;29:1683-702. DOI
                  PubMed PMC
               31.  Zhou M, Xiao MS, Li Z, Huang C. New progresses of circular RNA biology: from nuclear export to degradation. RNA Biol.
                  2021;18:1365-73. DOI PubMed PMC
               32.  Hashemi M, Khosroshahi EM, Daneii P, et al. Emerging roles of CircRNA-miRNA networks in cancer development and therapeutic
                  response. Noncoding RNA Res. 2025;10:98-115. DOI PubMed PMC
               33.  Wei Z, Shi Y, Xue C, et al. Understanding the dual roles of circHIPK3 in tumorigenesis and tumor progression. J Cancer.
                  2022;13:3674-86. DOI PubMed PMC
               34.  Singh DD, Yadav DK, Shin D. Non-coding RNAs in cancer therapy-induced cardiotoxicity: unlocking precision biomarkers for early
                  detection. Cell Signal. 2025;135:111982. DOI PubMed
               35.  Singh DD, Kim Y, Choi SA, Han I, Yadav DK. Clinical significance of microRNAs, long non-coding RNAs, and circRNAs in
                  cardiovascular diseases. Cells. 2023;12:1629. DOI PubMed PMC
               36.  Liu YY, Zhang LY, Du WZ. Circular RNA circ-PVT1 contributes to paclitaxel resistance of gastric cancer cells through the regulation
                  of ZEB1 expression by sponging miR-124-3p. Biosci Rep. 2019;39:BSR20193045. DOI PubMed PMC
               37.  Xue C, Li G, Lu J, Li L. Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression. Signal Transduct
                  Target Ther. 2021;6:400. DOI PubMed PMC
               38.  Zhao M, Lin M, Zhang Z, Ye L. Research progress of circular RNA FOXO3 in diseases (review). Glob Med Genet. 2025;12:100003.
                  DOI PubMed PMC
               39.  Shao Y, Song Y, Xu S, Li S, Zhou H. Expression profile of circular RNAs in oral squamous cell carcinoma. Front Oncol.
                  2020;10:533616. DOI PubMed PMC
               40.  Yan T, Tian X, Liu F, et al. The emerging role of circular RNAs in drug resistance of non-small cell lung cancer. Front Oncol.
                  2022;12:1003230. DOI PubMed PMC
               41.  Chen J, Yang J, Fei X, Wang X, Wang K. CircRNA ciRS-7: a novel oncogene in multiple cancers. Int J Biol Sci. 2021;17:379-89. DOI
                  PubMed PMC
               42.  Han D, Li J, Wang H, et al. Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma
                  progression. Hepatology. 2017;66:1151-64. DOI PubMed
               43.  Xia X, Li X, Li F, et al. A novel tumor suppressor protein encoded by circular AKT3 RNA inhibits glioblastoma tumorigenicity by
                  competing with active phosphoinositide-dependent Kinase-1. Mol Cancer. 2019;18:131. DOI PubMed PMC
               44.  Xu T, Wang M, Jiang L, et al. CircRNAs in anticancer drug resistance: recent advances and future potential. Mol Cancer. 2020;19:127.
                  DOI PubMed PMC
               45.  Zhang J, Luo Z, Zheng Y, Duan M, Qiu Z, Huang C. CircRNA as an Achilles heel of cancer: characterization, biomarker and therapeutic
                  modalities. J Transl Med. 2024;22:752. DOI PubMed PMC
               46.  Adhit KK, Wanjari A, Menon S, Siddhaarth K. Liquid biopsy: an evolving paradigm for non-invasive disease diagnosis and monitoring
                  in medicine. Cureus. 2023;15:e50176. DOI PubMed PMC
               47.  Wang M, Yu F, Li P, Wang K. Emerging function and clinical significance of exosomal circRNAs in cancer. Mol Ther Nucleic Acids.
                  2020;21:367-83. DOI PubMed PMC
               48.  Martinez-Dominguez MV, Zottel A, Šamec N, et al. Current technologies for RNA-directed liquid diagnostics. Cancers. 2021;13:5060.
                  DOI PubMed PMC
               49.  Wang K, Bai X, Xue Y, et al. Absolute quantification of circRNA using digital reverse transcription-hyperbranched rolling circle
                  amplification. Sens Actuators B Chem. 2023;375:132893. DOI
               50.  Masante L, Susin G, Baudet M. Droplet digital PCR for the detection and quantification of bona fide CircRNAs. In: Dieterich C, Baudet
                  M, editors. Circular RNAs. New York: Springer US; 2024. pp. 107-26. DOI
               51.  Bauer-Negrini G, Cordenonsi da Fonseca G, Gottfried C, Herbert J. Usability evaluation of circRNA identification tools: development of
                  a heuristic-based framework and analysis. Comput Biol Med. 2022;147:105785. DOI PubMed
               52.  Gaffo E, Buratin A, Dal Molin A, Bortoluzzi S. Sensitive, reliable and robust circRNA detection from RNA-seq with CirComPara2.
                  Brief Bioinform. 2022;23:bbab418. DOI PubMed PMC
               53.  Chen L, Wang C, Sun H, et al. The bioinformatics toolbox for circRNA discovery and analysis. Brief Bioinform. 2021;22:1706-28. DOI
                  PubMed PMC
               54.  Zhang N, Wang X, Li Y, et al. Mechanisms and therapeutic implications of gene expression regulation by circRNA-protein interactions
                  in cancer. Commun Biol. 2025;8:77. DOI PubMed PMC
                                                           44
   46   47   48   49   50   51   52   53   54   55   56